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E-mail address: haoxingx@umich.edu (H. Xu).The mucolipin family of Transient Receptor Potential (TRPML) proteins is predicted to encode ion
channels expressed in intracellular endosomes and lysosomes. Loss-of-function mutations of
human TRPML1 cause type IV mucolipidosis (ML4), a childhood neurodegenerative disease. Mean-
while, gain-of-function mutations in the mouse TRPML3 result in the varitint-waddler (Va) pheno-
type with hearing and pigmentation defects. The broad spectrum phenotypes of ML4 and Va appear
to result from certain aspects of endosomal/lysosomal dysfunction. Lysosomes, traditionally
believed to be the terminal ‘‘recycling center” for biological ‘‘garbage”, are now known to play indis-
pensable roles in intracellular signal transduction and membrane trafﬁcking. Studies employing
animal models and cell lines in which TRPML genes have been genetically disrupted or depleted
have uncovered roles of TRPMLs in multiple cellular functions including membrane trafﬁcking, sig-
nal transduction, and organellar ion homeostasis. Physiological assays of mammalian cell lines in
which TRPMLs are heterologously overexpressed have revealed the channel properties of TRPMLs
in mediating cation (Ca2+/Fe2+) efﬂux from endosomes and lysosomes in response to unidentiﬁed
cellular cues. This review aims to summarize these recent advances in the TRPML ﬁeld and to cor-
relate the channel properties of endolysosomal TRPMLs with their biological functions. We will also
discuss the potential cellular mechanisms by which TRPML deﬁciency leads to neurodegeneration.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The endolysosome system in the cell is comprised of early
endosomes (EEs), recycling endosomes (REs), late endosomes
(LEs), and lysosomes (LYs) and is essential for a variety of cellular
functions including membrane trafﬁcking, protein transport,
autophagy, and signal transduction (reviewed in Refs. [1,2]). EEs
are derived from the plasma membrane upon endocytosis and
are involved in intracellular trafﬁcking of components that are
sorted into recycling endosome or late endosome pathways
(Fig. 1). Lysosomes are membrane-enclosed compartments that
are derived from LEs and ﬁlled with hydrolytic enzymes. A hall-
mark feature of the endolysosome system is an acidic pH in the lu-
men (luminal pH is approximately 6, 5.5, and 4.5 in the EE, LE, and
LY, respectively), which is established and maintained by the V-
ATPase H+ pump [2]. The membrane potentials of endosomes or
lysosomes are not precisely known but are presumed to be positive
in the lumen (approximately in the range of +30 to +110 mV) based
on measurements from other related acidic organelles [1]. Similar
to other intracellular organelles, such as the endoplasmic reticu-
lum (ER) [3], endolysosomes also provide storage for intracellular
Ca2+ and have a luminal Ca2+ concentration ([Ca2+]lumen) of approx-chemical Societies. Published by Eimately 0.5 mM [4]. An unidentiﬁed H+–Ca2+ exchanger is thought
to maintain the intraendolysosomal Ca2+ gradient at the expense of
the H+ gradient [1,2,5]. The release of Ca2+ from endolysosomes
may play important roles in signal transduction [6,7] and mem-
brane trafﬁcking [2,5,8]. Although it is known that lysosomes fre-
quently fuse with the plasma membrane and other intracellular
membranes such as endosomes, autophagosomes, and phago-
somes under resting conditions or upon cellular stimulation, the
mechanisms underlying fusion events are not well established.
While Soluble NSF Attachment Protein Receptors (SNAREs) are
essential structural components involved in intracellular trafﬁck-
ing (e.g., membrane fusion and ﬁssion) [9], both small GTPase Rabs
[10] and phosphoinositides (PIPs) [11] function as important regu-
latory players. In addition, the level of juxtaorganellar Ca2+ also
plays a central role in regulating membrane trafﬁcking [12,13].
However, the ion channels responsible for intralysosomal Ca2+ re-
lease have still remained elusive. Candidate endolysosomal Ca2+
channels include several members of the transient receptor poten-
tial (TRP) protein family (i.e., TRPMLs, TRPV2, and TRPM2) and
the recently identiﬁed two-pore Ca2+ channels (TPCs) [1,6,7].
Emerging evidence suggests that the mucolipin subfamily of
TRP proteins (TRPMLs) consists of endolysosomal cation channels.
TRP channels are a large family of cation channels with diverse
physiological functions particularly in sensory signaling [14–16].
Similar to all other TRPs, TRPMLs are six transmembranelsevier B.V. All rights reserved.
EE
Exocytosis
Endocytosis
RE
pH 6.4
ML2
pH 6.0
ML3
PI(4,5)P2
PI(3)P
PI(3,5)P2
Ca2+
Rab7
Rab5
TRPML
 CaM
Arf6
H+
      AP
AP: autophagosome
AL: autolysosome
EE: early endosome
RE: recycling endosome
TGN: Trans-Golgi Network
LY: lysosome
LELH: late endosome and lysosome hydrid
 Syt VII pH 5.5
ML1-3
      AL
to TGN
ML1-3
pH 4.5
      LELH
LE
LY
Fig. 1. TRPMLs in the endocytic pathway. Intracellular compartments undergo cargo-dependent maturation (indicated by black arrows), membrane fusion (white arrows),
and ﬁssion/budding (red arrows). The molecular identities of intracellular compartments are deﬁned by speciﬁc recruitment of small G proteins (Rab and Arf GTPases) and
the composition of phosphoinositides (PIPs). Endolysosomes are Ca2+ stores with luminal Ca2+ concentration estimated to be approximately 0.5 mM. The pH of each organelle
is indicated. In endolysosomes, TRPML-mediated intra-endosomal Ca2+ release may activate Ca2+ sensor proteins such as Synaptotagmin (Syt) and calmodulin (CaM) to
trigger homotypic and heterotypic fusion. TRPML3 is present in early endosomes (EEs; pH 6.0; PI(3)P; Rab5), which are derived from the primary endocytic vesicles after
endocytosis. In addition to the late endocytic pathway, contents in the EE can also be sorted into recycling endosomes (RE; pH 6.4), which are subsequently recycled back to
the plasma membrane. TRPML2 is present in Arf6 – positive REs. The channel activity of TRPML2 (in RE) may regulate the activation of small GTPase Arf6, an important
regulator of the recycling pathway. EEs can undergo maturation (membrane trafﬁcking) to become late endosomes (LEs; pH 5.5; PI(3)P + PI(3,5)P2; Rab7). Membrane proteins
enter the degradation pathway following membrane invagination to form multi-vesicular bodies (MVB) in LEs. LEs can fuse with LYs (LYs; pH 4.5; PI(3)P + PI(3,5)P2; Rab7) to
form LE–LY hybrids. LYs can then be reformed from LE–LY hybrids. Other than fusion with LEs, LYs can also undergo fusion with autophagosomes (APs) to form
autolysosomes (ALs) or with the plasma membrane during lysosomal exocytosis. TRPML1-3 channels are predominantly localized in LEs and LYs. Activation of TRPML
channels by unidentiﬁed cellular cues may induce intralysosomal Ca2+ release. LEs, LYs, or hybrids of LEs and LYs will then undergo CaM- or Syt-dependent membrane fusion
or ﬁssion/budding. Retrograde transport vesicles, derived from EEs, LEs, or LYs upon membrane ﬁssion transport lipids and proteins in a retrograde direction to the trans-
Golgi Network (TGN).
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(see Fig. 2 for membrane topology). In mammals, there are three
TRPML proteins (TRPML1-3, also called MCOLN1-3). Loss-of-func-
tion mutations in the human TRPML1 gene cause type IV mucolip-
idosis (ML4), a devastating neurodegenerative disease that causes
mental retardation and retinal degeneration [17–19]. In addition,
some patients also develop iron deﬁcient anemia [18]. Gain-of-
function mutations of the mouse TRPML3 gene result in the vari-
tint-waddler (Va) phenotype that is characterized by deafness, cir-
cling behavior, and pigmentation defects [20]. The broad spectrum
of phenotypes for both ML4 and Va might result from certain as-
pects of endosomal/lysosomal dysfunction. TRPML1/ cells from
ML4 patients are characterized by the accumulation of enlarged
endosomal/lysosomal compartments (vacuoles) in which lipids
and other biomaterials accumulate, suggesting defective lysosomal
biogenesis and trafﬁcking [21,22]. Nevertheless, the mechanisms
of TRPMLs that are required for normal lysosomal functions are
not known largely due to the lack of reliable physiological assays.
Conventional assays used for assessing plasma membrane chan-
nels, such as the whole-cell patch-clamp technique, are not suit-
able for studying TRPMLs due to the inaccessible nature of the
lysosome. Fortunately, this technical barrier has recently been
overcome in a new series of studies using an activating mutation
strategy [23–26]. In addition, a modiﬁed patch-clamp techniquehas been developed that allows a direct recording on lysosomal
membranes [27,28]. This review aims to summarize recent ad-
vances in the ﬁeld and to correlate the channel properties of endo-
lysosomal TRPMLs with their currently established biological
functions.
2. TRPML tissue distribution and subcellular localization
In order to gain insight into the biological functions of TRPMLs,
it is important to know the relative expression levels of each indi-
vidual isoform in speciﬁc tissues. Unfortunately, most of the avail-
able TRPML antibodies are inadequate for this purpose and
therefore published data have measured TRPML mRNA expression
levels using nucleotide-based techniques such as real-time poly-
merase chain reaction (PCR), northern blot, and in situ hybridiza-
tion. In mammals, TRPML1 is expressed in every tissue with the
highest levels of expression located in the brain, kidney, spleen, li-
ver, and heart [19] (Table 1). Consistent with its ubiquitous expres-
sion pattern, the enlarged vacuole phenotype that is associated
with the loss of TRPML1 is observed in all cell types of ML4 patients
and TRPML1 knockout mice [17,29]. In contrast to TRPML1, the
expression of TRPML2 and TRPML3 is more restricted (Table 1).
Mouse TRPML2 has two alternatively spliced variants [30]. The
longer variant of TRPML2 (TRPML2lv) has an additional 28 amino
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Fig. 2. TRPMLs in the lysosome. (A) While the ionic compositions of the extracellular space and cytosol have been well established, ion concentrations in the lumen of
lysosomes are not clear. The luminal pH is between 4 and 5 and is established by a V-type ATPase. The [Ca2+]LY is approximately 0.5 mM and maintained by an unidentiﬁed
H+–Ca2+ exchanger. The resting membrane potential (DW) of the cell is approximately 70 mV (cytoplasmic-side negative). Based on studies of phagosomes, the membrane
potential across the lysosomal membrane is estimated to be approximately +30 mV (luminal-side positive). TRPMLs are permeable to Fe2+ (except for TRPML3) and Ca2+; none
of the TRPML isoforms are permeable to H+. Although wild-type TRPMLs are predominantly expressed in the lysosome, TRPMLVa proteins are present at the plasma
membrane. (B) Current–voltage (I–V) relationship of TRPML channels. All TRPMLs exhibit a strong inward rectiﬁcation.
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(TRPML2sv) [30]. Real-time PCR analysis revealed that TRPML2sv
has a higher expression level than TRPML2lv in most tissues and
is the dominant variant expressed in mouse thymus, spleen, and
kidney [30]. RT-PCR revealed that TRPML3 mRNA is detectable in
the thymus, lung, kidney, spleen, and eye [30,31]; in situ hybridiza-
tion revealed expression of TRPML3 in epithelial cells of the inner
ear, including strial and hair cells [26]. Using antibodies raised
against TRPML3, immunoreactivities were detected in hair cells
[20,26] and melanocytes of the skin [25]. TRPML3 protein was also
detected in several epithelial cell lines including HEK293, HeLa,
and the retinal pigmented epithelial cell line ARPE19 [32–34].
Interestingly, the expression level of TRPML2, but not TRPML3, is
altered in a tissue-speciﬁc manner in TRPML1/ cells [30]. It is
likely that the three isoforms of mammalian TRPMLs have unique
tissue-speciﬁc functions in addition to their shared cellular func-
tions. In contrast to mammals, Drosophila melanogaster and Caeno-
rhabditis elegans only express one TRPML protein [35,36].
TRPMLs primarily localize to a population of membrane-bonded
vesicles along the endocytosis and exocytosis pathways. Overex-
pression studies using TRPML1 tagged or fused with reporter
genes, such as EGFP or mCherry, have revealed that TRPML1 pri-
marily localizes to the lysosome-associated membrane protein
(Lamp-1) or Rab7-positive late endosomal and lysosomal (LEL)
compartments [27,32,33,37–42]. TRPML1 localization to the LEL
has been beautifully conﬁrmed by immunostaining and gradient
fractionation studies on endogenous proteins [32,34]. Lysosomal
localization of TRPML1 protein is likely mediated by Clathrin adap-
tor AP2-dependent internalization from the plasma membrane
and/or AP1/AP3-dependent trafﬁcking from the trans-Golgi Net-
work (TGN) by direct interaction with two individual di-leucine
motifs that exist near the N- and C-termini of TRPML1 [39,41,42].
Similar to TRPML1, TRPML2 and TRPML3 that were tagged and
overexpressed also accumulate in LEL compartments and co-local-
ize with Lamp-1 and Rab7 [32,33,40,43,44]. Immunolocalization
studies have also shown that TRPML2 localizes to the vesicles
along the long, tubular structures within cells in addition to the
LEL [43]. These long, tubular structures correspond to the recycling
endosomes of the GTPase ADP-ribosylation factor-6 (Arf-6) associ-ated pathway [43]. By using cellular fractionation and primary
antibodies raised against TRPML3, Kim et al. provided evidence
that TRPML3 localizes to LELs, EEs, and the plasma membrane
[32]. The plasma membrane localization of TRPML3 is consistent
with the substantial whole-cell currents that can be recorded from
TRPML3-expressing HEK293 cells [23–26].
3. Channel properties of TRPMLs
TRPML1 and TRPML2 are primarily localized to the LEL, making
it difﬁcult to characterize their channel properties. In contrast,
overexpressed, wild-type TRPML3 is present at the plasma mem-
brane and has been characterized using the whole-cell patch-
clamp technique [24,25]. These studies have shown that TRPML3
is an inwardly rectifying, Ca2+-permeable cation channel (thor-
oughly reviewed in Ref. [31]). TRPML3-mediated current (ITRPML3)
is inhibited by an acidic extracellular (analogous to the luminal
side) pH with H+ presumably binding to multiple histidine residues
within the TM1–TM2 loop [45]. Interestingly, ITRPML3 is potentiated
by the removal and subsequent re-addition of extracellular Na+
[24,45]. The physiological implications of these two observations
remain to be established. Mutation of mouse TRPML3 (A419P)
causes the varitint-waddler (Va) phenotype, which is characterized
by deafness, circling behavior, and pigmentation defects [20].
Much larger currents were seen for TRPML3A419P (TRPML3Va) com-
pared to wild-type TRPML3 under basal/non-stimulated conditions
[25], consistent with the high open probability of ITRPML3-Va [25,26].
ITRPML3-Va resembles ITRPML3 in the basic channel pore properties
including current–voltage (I–V), single channel conductance, and
ion selectivity [24–26]. However, since ITRPML3-Va cannot be further
activated by Na+ manipulation [24], the Va mutation is likely to
disrupt channel gating by locking the channel in an open state
[31]. Therefore, the reported Va-induced small alteration of Ca2+
permeability [45] could be secondary to the effect on gating. This
would be in accordance with the gating-permeation coupling phe-
nomenon observed in other TRPs [46].
The Va activating mutation approach has been used to effec-
tively characterized the pore properties of TRPML1 and TRPML2
in multiple studies [23,25,27,30]. Introduction of Va-like mutations
Table 1
The mammalian TRPML channels.
TRPML1 (MCOLN1) TRPML2 (MCOLN2) TRPML3 (MCOLN3)
Tissue expression Ubiquitously Thymus, liver, kidney,
heart, spleen
Cochlea, thymus, kidney, lung, eye, spleen, skin
(melanocytes), somato-sensory neurons
Subcellular localization Late endosome and lysosome (LEL) Recycling endosome, LEL Plasma membrane, early endosome, LEL
Ion selectivity Na+, K+, Ca2+, Mn2+, Fe2+, Mg2+, Zn2+, etc. Na+, K+, Ca2+, Fe2+ Na+, K+, Ca2+, Mg2+
Current–voltage
relationship (I–V)
Strong inwardly rectifying Strong inwardly rectifying Strong inwardly rectifying
Single channel conductance
in pS
76 (from 140 to 100 mV) and 11 (from 80 to
40 mV)
Not described 50
Activation mechanisms Voltage; NAADP (?); PKA (?); extracellular or
luminal low pH
Voltage; extracellular or
luminal low pH
Voltage; Na2+ removal followed by re-addition
Blockers and inhibitors Verapamil; Gd3+; La3+ Not described Verapamil; Gd3+; extracellular or luminal low pH
Interacting proteins TRPML2; TRPML3; Hsc70; Hsp40; ALG-2 TRPML1; TRPML3 TRPML1; TRPML2
Cellular functions Membrane trafﬁcking in late endocytic pathways;
autophagy; lysosomal biogenesis; lysosomal iron
release; lysosomal exocytosis; possible LEL pH
homeostasis
Membrane trafﬁcking in
late endocytic pathways
and Arf6-regulated
recycling pathway
Membrane trafﬁcking along endolysosomal
pathways; autophagy; possible hair cell function
Human disease Mucolipidosis type IV (ML4; MIM #252 650;
autosomal recessive lysosomal storage
neurodegenerative disease with progressive
psychomotor retardation, retina degeneration, iron-
deﬁciency, achlorhydria, and mental retardation);
ML4 cells show enlarged endolysosomes, lipid
accumulation, autophagic dysfunction,
mitochondrial dysfunction, possible acidiﬁcation
defect, and lipofuscin accumulation in the brain
Not described Not described
Genetic models (1) TRPML1 knockout mice: inclusion bodies,
enlarged vacuoles, psychomotor defect, ret-
inal degeneration, death at age approxi-
mately 8 months
(2) Cup-5 null C. elegans: enlarged vacuoles,
excess apoptotic cells, and embryonic
lethality
(3) Drosophila trpml mutant: defective autoph-
agy, impaired synaptic transmission, accu-
mulation of apoptotic cells, oxidative
stress, lipofuscin accumulation, mitochon-
drial dysfunction, motor defects, and mas-
sive neurodegeneration
Not described Varitint-waddler mouse (Va) with A419P mutation
in the 5th TM domain; Va(J) mouse with an
additional mutation at I362T; heterozygous and
homozygous mice exhibit pigmentation defects in
the skin, circling behavior with degeneration of
vestibular apparatus, and low fertility
References [18,19,22,23,25–28,30,35,39,47,52,61,77–80] [23,25,30,41,43] [20,23–26,30,32,33,45,81]
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(A396P) allowed for the characterization of the pore properties of
TRPML1 and TRPML2 using whole-cell recordings [25,27,28,30].
We initially reported that TRPML2sv-Va was functional but
TRPML2lv-Va was not [25,28]. However, a single mutation in our
original mouse TRPML2lv-Va clone might have actually been a
cloning artifact (as opposed to a polymorphism as originally
thought), since correction of this mutation resulted in a measur-
able inwardly rectifying whole-cell current [30] (Wang and Xu,
unpublished data; personal communication with Cuajunco and
Grimm). Similar to ITRPML3, both ITRPML1-Va and ITRPML2-Va are in-
wardly rectifying and Ca2+-permeable cationic currents. Using a
lysosome patch-clamp technique, Dong et al. were able to charac-
terize wild-type TRPML1 [27] and TRPML2 (Dong et al., unpub-
lished results) in their native membranes (LEL). Lysosomal ITRPML1
and ITRPML2 exhibited almost identical pore properties (I–V, kinet-
ics, and voltage-dependence) as their respective Va mutant chan-
nels, supporting the hypothesis that the activating mutation (Va)
is a useful approach for characterizing the pore properties of
TRPML1 and TRPML2. Nevertheless, whole lysosome ITRPML1-Va is
at least 10 times larger than whole lysosome ITRPML1 [27], suggest-
ing that Va is also a gain-of-function mutation in LEL. Previous
studies have resulted in very controversial results on the channel
properties of TRPML1 (summarized in Ref. [21]). However, the re-
ported currents from these studies contrast dramatically with
ITRPML1 and ITRPML1-Va data described above. For example, whole-cell
patch-clamp recordings of overexpressed TRPML1 were reported
to yield outwardly rectifying monovalent, cation-selective [37] or
H+-selective [47] channels. ITRPML and ITRPML-Va, however, are in-wardly rectifying and permeable to Ca2+, Na+, K+, and Fe2+/Mn2+,
but not H+ [25,27,28]. Although differences may exist for ion chan-
nel studies using different heterologous expression systems, it is
unlikely that different laboratories cannot reach a consensus on
the basic pore properties of one single channel protein. In the view
of the authors of this article, the inwardly rectifying currents (un-
der physiological conditions) are likely to represent the true elec-
trophysiological functions of TRPMLs. Consistent with the
overexpression studies, the endogenous TRPML-like current in
LEL is also strongly inwardly rectifying (Dong et al., unpublished
results).
Although the pore properties of TRPMLs have been well charac-
terized, the mechanisms of how TRPMLs are gated/activated under
physiological conditions are not known. Since the Va mutation ap-
pears to dramatically promote the open state of TRPML channels
[25,27,28], studies of ITRPML-Va may not yield useful information
regarding TRPML regulation. ITRPML1-Va and ITRPML2-Va are both
potentiated by low pH, however the effect is quite modest
[25,28]. In addition, H+ may have increased the single channel con-
ductance but most likely did not increase the open probability of
the channels. Therefore, the physiological implication of this pH
modulation remains to be established. Heterologously-expressed
wild-type TRPML3 is present in the plasma membrane [24,25,45],
which allows for the study of channel activation mechanisms.
Wild-type TRPML1 and TRPML2 might also be able to trafﬁc to
the plasma membrane under certain conditions or in speciﬁc cell
types, though these situations have not been reported. Another
possible method for investigating TRPML gating is to analyze lyso-
some recordings. Using this method, we are currently studying
X. Cheng et al. / FEBS Letters 584 (2010) 2013–2021 2017how overexpressed and endogenous TRPMLs are regulated by
luminal and cytosolic factors that are known to affect lysosomal
functions (Dong et al., unpublished ﬁndings). For TRPML3, Kim
et al. was able to investigate the activation mechanisms of ITRPML3
using whole-cell recordings and reported that ITRPML3 is dramati-
cally enhanced by Na+ manipulation (removal followed by re-addi-
tion) [24]. However, it remains to be established how TRPML3 is
activated by mechanisms that are physiologically more relevant.4. TRPML in membrane trafﬁcking
Human ML4 mutations cause the abnormal accumulation of
sphingolipids, phospholipids, acidic mucopholysaccharides, and
cholesterol in swollen/enlarged LEL-like vacuoles in all cell types
[22,48]. Consistent with this observation, abnormal lipid accumu-
lation and enlarged LELs are also seen in cells from TRPML1 knock-
out mice [29], TRPML/ (cup-5) C. elegans [36], and TRPML/
Drosophila [35]. Electron microscopy (EM) studies suggest that en-
larged LELs in TRPML/ cells are likely to be the late endosome–
lysosome hybrid organelles from which lysosomes are reformed
under normal conditions [49]. Since the hydrolase activity that is
involved in lipid processing is relatively normal [22] (but see Ref.
[47]), the defect observed in TRPML/ cells is most likely related
to the sorting and trafﬁcking processes of the endocytic pathway.
Analyses of trafﬁcking kinetics suggest that the defect is in the late
endocytic pathways only [22]. Speciﬁcally, the exit of lipids from
the LEL to the TGN is defective in ML4 cells [22,39]. In support of
these observations, shRNA-mediated knockdown of TRPML1
expression in mouse macrophages results in a similar defect in ret-
rograde lipid transport [40]. Taken together, TRPML1 is likely to be
required for the formation of transport vesicles from the LEL com-
partment to the TGN and for the reformation of lysosomes from the
late endosome–lysosome hybrid organelles [36,40,49]. This
hypothesis is supported by the observation that TRPML1 expres-
sion is dramatically increased following induction of lysosome bio-
genesis [50]. Since membrane ﬁssion and/or stabilization of
transport vesicles are known to be dependent on luminal Ca2+
[2,5,51] and/or intraluminal Ca2+ release [5,13], it is likely that
the Ca2+ permeability of TRPML1 is required for the membrane ﬁs-
sion from LEL compartments or late endosome–lysosome hybrids
and the biogenesis of both retrograde transport vesicles and lyso-
somes (Fig. 1). TRPML1 may also be required for the reformation
of lysosomes from autolysosomes [35,52].
Other trafﬁcking defects are also observed in TRPML/ cells.
ML4 ﬁbroblasts have been reported to exhibit a delay in the deliv-
ery of platelet-derived growth factor receptor (PDGFR) to lyso-
somes [52]. In mouse macrophages where TRPML1 protein level
has been reduced by shRNA, the transport of endocytosed mole-
cules to lysosomes is delayed [40]. Autophagosomes have also
been shown to accumulate in ML4 cells. This could be due to either
increased autophagosome formation or delayed fusion of auto-
phagosomes with lysosomes to form autolysosomes (AL) (Fig. 1)
[52]. ML4 ﬁbroblasts also show a defect in ionomycin-induced
lysosomal exocytosis [53]. However, this effect could be a second-
ary observation, since ionomycin (Ca2+ ionophore) presumably acts
directly on the Ca2+ sensor synaptotagmin VII (SytVII) thereby
bypassing upstream TRPML activation. Nevertheless, experiments
showing that HEK293 cells transfected with a gain-of-function mu-
tant TRPML1 exhibit enhanced lysosomal exocytosis provide addi-
tional evidence that TRPML1 plays a role in this process [28]. The
gain-of-function mutation is likely to have mimicked an unidenti-
ﬁed cellular stimulation to induce intralysosomal Ca2+ release
since these experiments were performed using a Ca2+-free extra-
cellular solution to exclude the involvement of the gain-of-func-
tion TRPML1 channels at the plasma membrane. Taken together,we hypothesize that TRPML1 plays a role in multiple membrane
fusion processes related to late endosomes and lysosomes
(Fig. 1). Membrane fusion in the endocytic pathway is dependent
on the release of luminal Ca2+ that occurs as a post-docking event
[54]. Using Ca2+ chelators in cell-free assays, Pryor et al. showed
that luminal Ca2+ is required for both lysosome reformation and
heterotypic fusion of late endosomes and lysosomes [13]. Release
of luminal Ca2+ is thought to promote the post-docking events
through the activation of Calmodulin (CaM) [13]. In consideration
of these data, it is possible that TRPML1 may be tightly regulated
to release Ca2+ as a mechanism of facilitating the endocytic process
in a correct spatiotemporal method. TRPML1, therefore, may play a
dual role in membrane fusion and ﬁssion in the late endocytic
pathways (late endosomes, lysosomes, autophagosomes, and the
plasma membrane).
In comparison to TRPML1, the role of TRPML2 and TRPML3 in
regulating membrane trafﬁcking is less well understood. TRPML2
and TRPML3 may function indirectly through the formation of het-
eromultimers with TRPML1, since both heterologously-expressed
[41] and endogenous TRPMLs [34] can physically associate with
each other (Table 1). However, the extent of co-localization ap-
pears to be limited [34]. Therefore, it is more likely that TRPML2
and TRPML3 functions are primarily cell type speciﬁc. In LEL, it is
reasonable to hypothesize that TRPML2/3 play a similar role in
membrane trafﬁcking as TRPML1. TRPML2 has been reported to
trafﬁc via the Arf6-associated recycling pathway in Hela cells
[43]. While overexpression of TRPML2 promotes efﬁcient activa-
tion of Arf6, inactivation of TRPML2 by a dominant-negative ap-
proach decreases recycling of CD59 proteins to the plasma
membrane [43]. Thus, TRPML2 may interact and cross-talk with
other trafﬁcking regulators to control cargo sorting. The localiza-
tion of TRPML3 is more dynamic with expression in multiple intra-
cellular compartments. The diverse expression of TRPML3 may
correlate with its role in membrane trafﬁcking [32,33]. Overex-
pression of TRPML3 causes enlarged early-endosome-like struc-
tures and defective delivery and degradation of EGF and EGFR
that is consistent with its expression in EEs [32,33]. Since heterol-
ogously-expressed TRPMLs display basal activity in the LEL [27], it
is possible that overexpression of TRPML3 promotes endosomal
membrane fusion. Interestingly, knockdown of TRPML3 appears
to enhance endocytosis and degradation [33], a result that is incon-
sistent with the role of TRPML1 in degradation and trafﬁcking in
the late endocytic pathways [22,39,40]. It is possible that this ob-
served effect is due to a function of TRPML3 in early endocytic
pathways. The exact step where TRPML3 functions in the early
endocytic pathway is still not clear. While Kim et al. showed that
TRPML3 overexpression decreases constitutive and regulated
endocytosis in HEK and HeLa cells [32], Martina et al. found that
internalization of EGFR is not affected but that its delivery from
the plasma membrane to the lysosome is impaired in human epi-
thelial cells [33]. It is possible that these observed differences are
due to the use of different cell types. Finally, TRPML3 may also
be involved in the regulation of autophagy since both overexpres-
sion and knockdown of TRPML3 affect autophagy [32,33].
It is yet unclear how TRPMLs coordinate with the other key reg-
ulators of vesicle trafﬁcking such as GTPases (Rab and Arf) and
phosphoinositides since the endogenous activators of TRPMLs have
not been identiﬁed. Constitutive activation of Rab5 causes enlarged
early endosomes by stimulating homotypic fusion [10]. This is
reminiscent of the enlarged endosomes seen in cells with TRPML3
overexpression. It is possible that Rab5 may recruit effectors to
activate TRPMLs. Alternatively, the activity of TRPMLs may regu-
late the activity of Rabs, as shown in the case of TRPML2 and
Arf6 GTPase [43]. Similarly, alterations of endolysosomal phospho-
inositide (PIP) levels (PI(3)P and PI(3,5)P2) also results in enlarged
endolysosomes and defective endosome-to-TGN retrograde traf-
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abnormal late endocytic trafﬁcking phenotype seen in ML4 cells.
It is possible that TRPMLs are regulated directly by PIPs as shown
for many other plasma membrane TRPs [55]. Alternatively, TRPMLs
may regulate key enzymes involved in PIP production or hydroly-
sis. Taken together, TRPMLs may cross-talk with these proteins
and/or lipids to regulate endolysosomal trafﬁc. Since membrane
trafﬁcking is an active process, we expect that TRPMLs would be
frequently activated in the intact cell, unlike the situation in a lyso-
some recording conﬁguration in which there is not substantial
channel activity. It is worth noting that like most other TRPs, over-
expressed TRPMLs tend to exhibit basal currents. However, as
TRPMLs do not exhibit signiﬁcant voltage-dependent inactivation,
even a small TRPML current may lead to substantial Ca2+ release.
Therefore, it is necessary for TRPMLs to be tightly regulated in
the lysosome. It is likely that TRPMLs are only transiently activated
in the intact cell. TRPML-mediated channel activation may be able
to be captured as ‘‘spontaneous” lysosomal Ca2+ release events
using high-resolution, live imaging techniques in the near future.
Different Ca2+ sensors might be recruited in a compartment-spe-
ciﬁc manner downstream of Ca2+ release. While CaM has been re-
ported to be functional in late endosomes [13,54,56], SytVII might
convert the signal into Ca2+-dependent fusion with the plasma
membrane [57]. Recently, Vergarajauregui et al. reported that
ALG-2, a penta-EF-hand protein, physically associated with
TRPML1 but not TRPML2 or TRPML3 [58]. ALG-2 might also serve
as a Ca2+ sensor to couple TRPML1 activation to endolysosomal fu-
sion/ﬁssion events. Interestingly, the interaction of TRPML1 and
ALG-2 is strongly dependent on Ca2+, suggesting that this interac-
tion is physiologically signiﬁcant. Future research may indicate
whether ALG-2 also plays a role in the modulation of TRPML chan-
nel activity in the LEL.5. TRPMLs in signal transduction
Accumulating evidence suggests that a modest Ca2+ release
from lysosomes plays an indispensable role in the transduction
of extracellular signals by inducing a large and rapid release of
Ca2+ from the ER through the inositol 1,4,5-trisphosphate receptor
(IP3R) or ryanodine receptor (RyR) [7,59]. However, the mecha-
nisms by which Ca2+ is released from lysosomes has remained elu-
sive. There are two signiﬁcant questions that remain unanswered.
First, it is not known which intracellular messenger is generated
upon extracellular stimulation. Nicotinic acid adenine dinucleotide
phosphate (NAADP) has been an attractive candidate that is be-
lieved to induce Ca2+ release from lysosomes [7,59]. Second, iden-
tiﬁcation of the lysosome Ca2+ channels that are activated by
NAADP and other lysosome-acting cytosolic factors remains elu-
sive. TRPMLs could potentially be the lysosomal Ca2+ release chan-
nels based on their subcellular location and Ca2+ permeability.
Zhang et al. recently showed that a NAADP-sensitive current could
be blocked by an anti-TRPML1 antibody or reduced by TRPML1-
speciﬁc siRNA using reconstituted lipid bilayers from biochemi-
cally puriﬁed lysosomal membranes [60,61]. One caveat of these
studies is that the NAADP-activated current was Cs+ permeable
and possessed a linear I–V, two properties not shared by ITRPML1.
Nevertheless, ET-1, a known NAADP stimulator in coronary arterial
myocytes [60], was found to induce a local Ca2+ release from lyso-
somes followed by a global Ca2+ rise [62]. This response was signif-
icantly reduced after pre-treatment with TRPML1-speciﬁc siRNA
[60]. It is possible that TRPML1 may form heteromultimers with
other candidate NAADP receptors such as TPCs [7]. Future work
will be required to clarify the role of TRPML1 in lysosomal Ca2+ sig-
naling that is mediated by NAADP or other lysosome-acting intra-
cellular messengers.6. TRPMLs in endolysosomal H+ homeostasis
Lysosomal H+ homeostasis is known to play an essential role in
multiple lysosome-mediated functions. First, a change of luminal
pH may dramatically affect the functions of acidic hydrolytic en-
zymes in the lysosome and impair the degradative functions occur-
ring in the lysosome [5]. Second, similar to Ca2+, luminal H+ is
known to affect membrane fusion/ﬁssion via unknown mecha-
nisms [2,5]. Recently, Miedel et al. developed an alternative model
to explain ML4 pathogenesis based on the evidence that lysosomal
pH in ML4 cells or cells treated with TRPML1-speciﬁc siRNA is low-
er than in normal cells [47,63]. This newmodel is referred to as the
‘‘metabolic model” as opposed to the aforementioned ‘‘biogenesis”
or ‘‘trafﬁcking” model. The central idea of the ‘‘metabolic model”
hypothesizes that a decreased lysosomal pH may interfere with
the degradation of internalized lipids since H+ ions are important
for sorting processes and proper function of lysosomal acid hydro-
lases. If this model is proven to be correct, enzyme therapies would
be an effective method to treat ML4 [63].
Despite data supporting this newly proposed model, there are
several observations that contradict this hypothesis. Firstly, it is
not immediately clear what causes lysosomal hyperacidiﬁcation
in the absence of TRPML1 given that ITRPML and ITRPML-Va exhibit
no permeability to protons [25]. However, although ITRPML3 is
H+-impermeable and is indeed suppressed by low pH, overexpres-
sion of TRPML3 results in the alkalization of endolysosomes [33].
Therefore, it is likely that H+ homeostasis is regulated by intralys-
osomal Ca2+ release possibly through an unidentiﬁed Ca2+–H+ ex-
changer. Leucine zipper/EF hand-containing transmembrane-1
(Letm1), the recently identiﬁed mitochondrial Ca2+–H+ exchanger,
can function in a bidirectional manner [64]. Similarly, TRPML-
mediated juxtaorganellar [Ca2+]cyt elevation may induce H+ efﬂux
through a lysosomal counterpart of Letm1. It remains to be deter-
mined whether lysosomal hyperacidiﬁcation associated with loss
of TRPML1 is caused by such indirect mechanisms. Secondly,
reduction of lysosomal pH in ML4 cells is still controversial [39]
since hypoacidiﬁcation and no change of lysosomal pH have also
been observed in ML4 cells [22,65]. Impaired H+ homeostasis may
affect the activity of a Ca2+–H+ exchanger and/or luminal Ca2+
buffering and could lead to impaired Ca2+ homeostasis. However,
lysosomal Ca2+ content appears to be normal in ML4 cells [66]. Fi-
nally, based on the metabolic model, it is argued that the trafﬁck-
ing defect in ML4 cells may be due to the secondary effect of
gradual and chronic lipid accumulation [63]. However, since aber-
rant lipid trafﬁcking in ML4 cells was rescued by acute overex-
pression of wild-type TRPML1 [39], the secondary effect or
feedback inhibition is likely to be present also in TRPML1 siR-
NA-treated cells.7. TRPMLs in lysosomal iron release
In most mammalian cells iron is acquired through the endocy-
tosis of Fe3+-bound transferrin receptors. Iron may also enter the
endocytic pathways via autophagic ingestion of iron-binding pro-
teins, for example, cytochrome C [67]. After reduction by an endo-
lysosomal ferrireductase, Fe2+ is released from the endosome or
lysosome into the cytoplasm via the Fe2+ permeable channels or
transporter [67]. As mentioned above, ITRPML1 is permeable to both
Ca2+ and Fe2+/Mn2+. Since TRPML1 is localized to the LEL, it has be-
come a strong candidate as an endolysomal Fe2+ release channel
[27]. In support of these data, some ML4 patients were reportedly
associated with iron-deﬁciency and/or anemia [18].
Dong et al. has shown that TRPML1 can function as a Fe2+ per-
meable channel in the LEL based on patch-clamping LEL mem-
branes [27]. Using iron imaging and staining methods, it was
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levels and an increase of intralysosomal Fe2+ levels when com-
pared to control cells [27]. The authors proposed that Fe2+ release
from endosomes and lysosomes is speciﬁcally blocked due to a loss
of function of TRPML1. Intralysosomal iron overload caused by a
TRPML1-deﬁciency may lead to serious physiological conse-
quences and could contribute to the neurodegeneration seen in
ML4 patients (to be discussed below). Fe2+ permeability is not a
general feature of all TRPML isoforms. TRPML2, but not TRPML3,
is also permeable to Fe2+ (Dong et al., 2008), suggesting a cell type
speciﬁc function for TRPML2. For example, TRPML2 is expressed on
B and T lymphocytes [40,44] and iron metabolism is important for
lymphocyte maturation and function [68]. As impaired function of
parietal cells and achlorhydria are seen in all ML4 patients [18],
TRPML1 and TRPML2 might contribute to the systemic iron metab-
olism in mechanisms independent of Fe2+ permeability.
The fact that TRPML1 plays dual roles in iron metabolism and
lysosomal Ca2+ signaling may seem counterintuitive. However,
since most TRPs are non-selective for cations, it is not surprising
that many of them exhibit dual permeability to ions such as Na+
and Ca2+, each of which is involved with a distinct cellular output.
When TRPs in somato-sensory neurons are activated by sensory
cues such as temperature, Na+ inﬂux-mediated membrane depo-
larization is the major signal that mediates greater than 90% of
the inward current [69]. Membrane depolarization leads to the
propagation of an action potential along the axon that carries the
information to the spinal cord and brain. Sensory activation of TRPs
also results in small amounts of Ca2+ inﬂux, that is sufﬁcient to
cause sensory adaption and/or peptide release from sensory neu-
rons [15,69]. Although TRPML1 is permeable to both Fe2+ and
Ca2+, TRPML1-deﬁency results in impaired Fe2+ homeostasis [27]
but normal Ca2+ homeostasis [66]. The explanation for this differ-
ence may be the fact that the lysosomal Ca2+ gradient is dynami-
cally maintained by the activity of the putative H+–Ca2+
exchanger while lysosomal Fe2+ is mainly controlled by the release
pathway. In order to separate the effects of Ca2+ versus Fe2+,
TRPML1 mutations that cause a selective disruption of individual
permeability may prove insightful.8. TRPMLs in neurodegeneration
The primary symptom of ML4 patients and TRPML1 KO mice is
neurological despite the fact that TRPML-deﬁciency causes a clear
cellular phenotype in all cell types [17,70]. Massive neuronal cell
death and axonal degeneration are also seen in the brains of
TRPML/ ﬂies [35]. Although glial cell death can also be detected
in the ﬂy brain, successful rescue of cell death by neuron-speciﬁc
expression of TRPML suggests that non-neuronal cell death is sec-
ondary to neuronal death [35]. Neuronal cell death increases as an
animal ages possibly because of an accumulation of toxic factors
[35,70]. One potential factor is lipofuscin, which speciﬁcally accu-
mulates in the brains of TRPML1 KO mice and TRPML/ ﬂies
[35,70]. Lipofusin accumulates primarily in the lysosomes of
TRPML/ cells [35,70] and its production is likely to be a direct re-
sult of TRPML-deﬁciency. Indeed, the Ca2+ and Fe2+ permeability of
TRPML1 is sufﬁcient to explain lipofusin production in TRPML/
cells. First, impaired Ca2+ release may result in trafﬁcking defects
and the delayed exit of lipids from the LEL compartment. This de-
layed exit suggests that TRPML2, TRPML3, or other lysosomal Ca2+
channels may compensate for the deﬁciency. Alternatively, less
efﬁcient trafﬁcking pathways may exist in the cell. Regardless, this
observed trafﬁcking defect may still be tolerated by most ML4 cells
since the primary symptom of ML4 patients is neurological defects
despite the trafﬁcking defect and enlarged LEL phenotype observed
in all cell types [17]. Second, lysosomal Fe2+ overload associatedwith loss of TRPML1 may convert the accumulated lipids (due to
a trafﬁcking defect) into non-degradable lipofuscin under oxidative
conditions through increase production of reactive hydroxyl radi-
cals (OH; Fenton reaction) [71]. In proliferating cells, lysosomal
lipofuscin may not be toxic since it can be diluted during cell divi-
sion [71]. However, in non-proliferative postmitotic cells such as
neurons, accumulation of lipofuscin can result in cell death and
neurodegeneration. It is hypothesized that correcting either the
Ca2+ or Fe2+ defect may attenuate the symptoms of ML4 [67].
Therefore, lysosome-targeting iron chelators may be a useful ther-
apy for ML4 [67].
Lipofuscin accumulation is often associated with disrupted
autophagy, a lysosome-mediated degradation process that is im-
paired in many neurodegenerative diseases [72]. Lipofuscin is a
non-degradable factor that may cause signiﬁcant impairment of
normal functions of lysosomes when in excess [71]. There are
at least three basic functions of lysosomes: digestive and auto-
phagic functions, signal transduction, and membrane trafﬁcking.
All of these functions can be inhibited by lipofuscin production.
Indeed, impairment of autophagy has been reported in TRPML/
 cells [35,52,73] and TRPML1 interacts directly with the auto-
phagic machineries [73]. In addition, overexpression of TRPMLs
also results in an inhibition of autophagy [32,33]. Thus TRPMLs
may have a direct role in autophagy that is independent of lipo-
fuscin accumulation. Similarly, loss-of-function of TRPML1 affects
membrane trafﬁcking in a direct and indirect (lipofuscin-depen-
dent) manner. Impaired autophagy appears to be a general fea-
ture of many lysosomal storage diseases [21]. Mitochondrial
fragmentation is commonly seen in ML4 and other storage dis-
eases since autophagy is required for recycling of damaged mito-
chondria [21,66]. Impaired mitochondrial function in turn causes
oxidative stress [74]. During oxidative stress, TRPML1-deﬁciency
causes intralysosomal Fe2+ overload and an increase in the pro-
duction of free radicals and lipofuscin. Notably, intralysosomal
Fe2+ concentration increases signiﬁcantly during autophagic
ingestion of mitochondria, which are known to contain abundant
iron-binding proteins [71]. Therefore, one question to ask is how
lipofuscin accumulation causes neurodegeneration. Since lipofus-
cin accumulation causes a signiﬁcant impairment of membrane
trafﬁcking and autophagy, the subsequent effects of impaired
autophagy, mitochondria fragmentation, oxidative stress, intralys-
osomal overload, and continued lipofuscin production may con-
stitute a vicious cycle that leads to neuronal cell death and
axonal degeneration. From a therapeutic point of view, breaking
the cycle may protect neurons from degradation. For example,
reducing oxidative stress by overexpressing HSP70 chaperone
protein in neurons was able to break the cycle and attenuate neu-
rodegeneration [35]. Along this line, correcting either the Ca2+ or
Fe2+ defect might attenuate neurodegeneration and the neurolog-
ical symptoms of ML4.9. TRPML in other physiological functions
TRPMLs may also indirectly contribute to neurodegeneration.
Recently, Venkatachalam et al. found that overexpression of Dro-
sophila TRPML in non-neuronal cells was able to signiﬁcantly re-
duce neuronal cell death [35]. Further analysis suggested that
Drosophila TRPML is required for clearance of apoptotic neurons
by glial and immune cells. It is not known whether mammalian
TRPMLs have a similar function. However, considering the expres-
sion of all three TRPML proteins in lymphoid organs, it is possible
that there is a general function for all TRPML members in immune
cells. Since the reduction of oxidative stress in non-neuronal cells
is ineffective in attenuating neurodegeneration [35], the mecha-
nism by which TRPMLs are required for the functions of immune
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nothing that while there are three mammalian TRPML isoforms,
C. elegans and Drosophila only express one single TRPML protein.
C. elegans and Drosophila TRPML mutants appear to exhibit more
severe symptoms than ML4 patients and TRPML1 KO mice
[18,29,35,36]. Therefore, TRPML2 and TRPML3 may also participate
in the non-neuronal functions such as those occurring in immune
cells. Human TRPML2 has been shown to co-localize with major
histocompatibility complex class I (MHC-I) and CD59 antigen
[43], whereas mouse TRPML1 has been shown to co-localize with
MHC-II in macrophage cell lines [40]. Together, these data suggest
that TRPMLs are possibly involved in immune cell development,
differentiation, and antigen processing.
In addition to their putative involvement in neurodegeneration,
TRPMLs may have other physiological functions as well. Although
loss-of-function studies reveal a role of TRPMLs in neurodegenera-
tion, their neuronal functions under physiological conditions are
not clear. Neurite outgrowth is known to be dependent on lyso-
somal exocytosis [75], a process that involves TRPML1 activity
[1,28]. In astrocytes, release of certain transmitters such as ATP is
dependent on lysosomal exocytosis [76]. TRPML1 is also required
for normal functions of secretory epithelial cells. For example, acid
secretion from parietal cells is signiﬁcantly reduced in ML4 pa-
tients [18]. Finally, although an abundance of data describe the
intracellular functions of TRPMLs, the potential role of TRPMLs at
the plasma membrane cannot be excluded. In specialized cells
and/or under certain conditions, TRPMLs may be present and func-
tional in the plasma membrane. This is especially true for TRPML3,
which exhibits whole-cell currents when heterologously expressed
in a variety of cell lines. The availability of TRPML2 and TRPML3 KO
studies will help facilitate our understanding of their physiological
functions.10. Summary, perspectives, and future directions
TRPMLs channels have been found to be localized to intracellu-
lar vesicles and interact with a variety of vesicular proteins. The
basic channel pore properties of TRPMLs have been characterized,
however the gating regulation is currently not known. Although
functional studies suggest that TRPMLs play active roles in mem-
brane fusion and ﬁssion, signal transduction, and vesicular homeo-
stasis, the exact mechanisms of these functions have not been
elucidated. In the future, we hope to see the advancement of our
knowledge of TRPMLs in the following areas:
1. Identiﬁcation of TRPML regulators and activators, which will
help further characterize the roles of TRPMLs in signal transduc-
tion and/or membrane trafﬁcking.
2. Development of speciﬁc antibodies to detect endogenous
TRPMLs. With these research tools, a full knowledge of TRPML
subcellular localization and tissue-expression pattern can be
obtained.
3. With the development of TRPML2 and TRPML3 KO mice, more
cell type speciﬁc functions will be revealed for TRPML2 and
TRPML3.
4. The use of real-time live imaging methods to capture TRPML-
mediated juxtaorganellar Ca2+ transients. These seemingly
‘‘spontaneous” events may correlate with membrane fusion
events that can be monitored with ﬂuorescence imaging
approaches.
5. Ion imaging methods will be applied to accurately measure
luminal ion concentrations during both basal and stimulated
states. This will provide basic information about the electric
properties of endolysosomes and vesicles to better understand
how TRPMLs function in these compartments.Acknowledgements
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